Abstract
The newly discovered phenomenon of RNA interference (RNAi) offers the dual facility of selective viral gene silencing coupled with ease of tailoring to meet genetic variation within the viral genome. Such promise identifies RNAi as an exciting new approach to treat virus-induced diseases, including virus-induced cancers. RNAi can be induced using small interfering RNA (siRNA). Synthetic siRNA targets homologous mRNA for degradation, and this process is highly efficient. Using cervical cancer cells as a model, we demonstrate RNAi for viral oncogenes Cervical cancer is the second most common cancer in women worldwide and is caused by human papillomavirus (HPV). Silencing of HPV E6 and E7 gene expression was achieved using siRNAs to target the respective viral mRNAs. E6 silencing induced accumulation of cellular p53 protein, trans activation of the cell cycle control p21 gene, and reduced cell growth. By contrast, E7 silencing induced apoptotic cell death. HPV-negative cells appeared to be unaffected by the antiviral siRNAs. Thus siRNA can induce selective silencing of exogenous viral genes in mammalian cells, and the process does not interfere with the recovery of cellular regulatory systems previously inhibited by viral gene expression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411,428–429.
Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T, and Weber, K. (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114,4557–4565.
Elbashir, S. M., Harborth, J., Weber, K., and Tuschl, T. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199–213.
Sharp, P. A. (2001) RNA interference-2001. Genes Dev. 15,485–490.
Brummelkamp, T. R., Bernards, R., and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553.
Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A., and Herweijer, H. (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32, 107–108.
Martinez, L. A., Naguibneva, I., Lehrmann, H., et al. (2002) Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc. Natl. Acad. Sci. USA 99, 14849–14854.
Wang, B., Matsuoka, S., Carpenter, P. B., and Elledge, S. J. (2002) 53BP1, a mediator of the DNA damage checkpoint. Science 298, 1435–1438.
Jiang, M. and Milner, J. (2003) Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev. 17, 832–837.
Milner, J. (2003) RNA interference for treating cancers caused by viral infection. Expert Opin. Biol. Ther. 3, 459–467.
Jiang, M. and Milner, J. (2002) Selective silencing of viral gene expression in HPVpositive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21, 6041–6048.
Thompson, J. D. (2002) Applications of anti-sense and siRNAs during preclinical drug development. Drug Discov. Today 7,912–917.
Shuey, D. J., McCallus, D. E., and Giordano, T. (2002) RNAi: gene-silencing in therapeutic intervention. Drug Discov. Today 7, 1040–1046.
Sullenger, B. A. and Gilboa, E. (2002) Emerging clinical applications of RNA. Nature 418, 252–258.
Carmichael, G. G. (2002) Silencing viruses with RNA. Nature 418, 379–380.
Cullen, B. R. (2002) RNA interference: antiviral defence and genetic tool. Nat. Immunol. 3, 597–599.
Lee, N. S., Dohjima, T., Bauer, G., et al. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500–505.
Jacque, J. M., Triques, K., and Stevenson, M. (2002) Modulation of HIV-1 replication by RNA interference. Nature 418,435–438.
Novina, C. D., Murray, M. E, Dykxhoorn, D. M., et al. (2002) siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8, 681–686.
Capodici, J., Kariko, K., and Weissman, D. (2002) Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169, 5196–5201.
Gitlin, L., Karelsky, S., and Andino, R. (2002) Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418,430–434.
Randall, G., Grakoui, A., and Rice, C. M. (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 235–240.
Wilson, J. A., Jayasena, S., Khvorova, A., et al. (2003) RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. USA 100,2783–2788.
Hamasaki, K., Nakao, K., Matsumoto, K., Ichikawa, T., Ishikawa, H., and Eguchi, K. (2003) Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 543, 51–54.
Ge, Q., McManus, M. T., Nguyen, T., et al. (2003) RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA 100, 2718–2723.
Ausubel, F. M., Brent, R., Kingston, R. E., et al. (eds.) (1995) Current Protocols in Molecular Biology. John Wiley & Sons, New York.
Harlow, E. and Lane, D. (eds.) (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 420
Holen, T., Amarzguioui, M., Wiiger, M. T., Babaie, E., and Prydz, H. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30, 1757–1766.
Kawasaki, H., Suyama, E., Iyo, M., and Taira, K. (2003) siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res. 31, 981–987.
Song, E., Lee, S. K., Wang, J., et al. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347–351.
Amarzguioui, M., Holen, T., Babaie, E., and Prydz, H. (2003) Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31, 589–595.
Hamada, M., Ohtsuka, T., Kawaida, R., et al. (2002) Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs. Antisense Nucleic Acid Drug Dev. 12, 301–309.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Jiang, M., Milner, J. (2005). Selective Silencing of Viral Gene E6 and E7 Expression in HPV-Positive Human Cervical Carcinoma Cells Using Small Interfering RNAs. In: Lieberman, P.M. (eds) DNA Viruses. Methods in Molecular Biology, vol 292. Humana Press. https://doi.org/10.1385/1-59259-848-X:401
Download citation
DOI: https://doi.org/10.1385/1-59259-848-X:401
Publisher Name: Humana Press
Print ISBN: 978-1-58829-353-4
Online ISBN: 978-1-59259-848-9
eBook Packages: Springer Protocols